High Point Advisor Group LLC Novavax Inc Transaction History

High Point Advisor Group LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$36.28 - $75.29 $40,960 - $85,002	-1,129 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$177.8 - $270.58 $200,736 - $305,484	1,129 New	1,129 $234,000
Q2 2021 Jul 29, 2021	SELL	$121.0 - $257.67 $523,930 - $1.12 Million	-4,330 Closed	0 $0
Q1 2021 Apr 12, 2021	SELL	$112.98 - $319.93 $551,003 - $1.56 Million	-4,877 Reduced 52.97%	4,330 $778,000
Q4 2020 Feb 10, 2021	BUY	$78.74 - $139.5 $724,959 - $1.28 Million	9,207 New	9,207 $2.91 Million

292

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $630M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of High Point Advisor Group LLC, based on Form 13F filings with the SEC.

Stay updated on High Point Advisor Group LLC with notifications on news.